Cargando…
CD20 expression sub-stratifies standard-risk patients with B cell precursor acute lymphoblastic leukemia
Patients with standard-risk adult acute lymphoblastic leukemia (ALL) treated with chemotherapy do not have satisfactory outcomes. To more precisely classify ALL patients and optimize treatment, we re-evaluated the risk stratification system by examining CD20 expression and other classic risk factors...
Autores principales: | Yang, ShenMiao, Wang, Jing, Zhao, Ting, Jia, JinSong, Zhu, HongHu, Jiang, Hao, Lu, Jin, Jiang, Bin, Shi, HongXia, Liu, YanRong, Lai, YueYun, Xu, LanPing, Huang, XiaoJun, Jiang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739646/ https://www.ncbi.nlm.nih.gov/pubmed/29285259 http://dx.doi.org/10.18632/oncotarget.22207 |
Ejemplares similares
-
The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Serbanica, Andreea Nicoleta, et al.
Publicado: (2023) -
Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies
por: LU, JIN, et al.
Publicado: (2014) -
PB1754: HOMOZYGOUS DELETION OF ETV6: EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OR PRECURSOR T-LYMPHOBLASTIC LYMPHOMA
por: Álvarez, Miguel Ángel Perera, et al.
Publicado: (2023) -
Case series of precursor B-cell lymphoblastic lymphoma
por: Kim, Jin Yong, et al.
Publicado: (2014) -
Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
por: Park, Borae G., et al.
Publicado: (2011)